{
    "clinical_study": {
        "@rank": "20012", 
        "acronym": "IPF-PRO", 
        "arm_group": {
            "arm_group_label": "Subjects with recent IPF diagnosis", 
            "description": "Subjects who have been diagnosed with IPF in the 12 months preceding enrollment"
        }, 
        "biospec_descr": {
            "textblock": "Whole blood for DNA collected at enrollment. Plasma and serum samples collected at\n      enrollment and approximate 6-month intervals throughout study follow-up."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This registry will collect data on the strategies used to achieve a diagnosis of Idiopathic\n      Pulmonary Fibrosis (IPF) and the treatment and management efforts applied throughout study\n      follow-up, clinical outcome events and patient reported outcome data.  Blood samples will be\n      collected periodically throughout the study for use in future research efforts."
        }, 
        "brief_title": "Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry", 
        "completion_date": {
            "#text": "June 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Idiopathic Pulmonary Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Fibrosis", 
                "Pulmonary Fibrosis", 
                "Idiopathic Pulmonary Fibrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Ability to read and write in English\n\n          -  Willing and able to provide informed consent\n\n          -  Confirmed diagnosis of IPF by the enrolling facility in last 12 months\n\n          -  Age > 40 years\n\n        Exclusion Criteria:\n\n          -  Malignancy, treated or untreated, other than skin cancer, within the past 5 years.\n\n          -  Currently listed for lung transplantation at the time of enrollment."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "40 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects diagnosed with IPF in the 12 months preceding enrollment, identified at one of\n        the enrolling tertiary care centers."
            }
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01915511", 
            "org_study_id": "Pro00046131"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Idiopathic pulmonary fibrosis", 
            "Pulmonary fibrosis", 
            "IPF"
        ], 
        "lastchanged_date": "March 3, 2014", 
        "number_of_groups": "1", 
        "official_title": "Prospective Outcomes Registry of Subjects With Idiopathic Pulmonary Fibrosis", 
        "overall_contact": {
            "email": "rex.edwards@duke.edu", 
            "last_name": "Rex H Edwards", 
            "phone": "919-668-8499"
        }, 
        "overall_official": {
            "affiliation": "Duke Clinical Research Institute, Duke University", 
            "last_name": "Scott Palmer, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Characterize and describe the natural history of patients with a recent confirmed diagnosis of IPF, with emphasis on demographics, co-morbidities, medications, and risks for disease progression or death.", 
                "measure": "Data on natural history of IPF.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years"
            }, 
            {
                "description": "Understand the current practice patterns for diagnosis of IPF.", 
                "measure": "Data on current practice patterns for diagnosis of IPF.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "description": "Describe the impact of IPF on patient quality-of-life (QOL).", 
                "measure": "Data on impact of IPF on patient quality of life.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "description": "Collect longitudinal bio-samples for future research on disease presentation, progression, and subject response to clinical interventions.", 
                "measure": "Blood samples for future research.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01915511"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Identify factors associated with participation in interventional clinical trials, as part of a patient's care plan.", 
                "measure": "Data on clinical trial participation and management practices.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years"
            }, 
            {
                "description": "Compare disease-specific management practices with existing guidelines.", 
                "measure": "Data on management practices compared to existing guidelines.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "description": "Determine the influence of center-specific practices on patient outcomes.", 
                "measure": "Data on center-specific practices on outcomes.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }
        ], 
        "source": "Duke University", 
        "sponsors": {
            "collaborator": {
                "agency": "Boehringer Ingelheim", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "5 Years", 
        "verification_date": "March 2014"
    }
}